Protein and membrane trafficking pathways are critical for cell and tissue homeostasis.
Introduction
The molecular machinery underlying the processes of protein transport and secretion has been conserved from yeast to mammalian cells, being essential to maintain specificity and communication between organelles, exocytosis and endocytosis. Fully one-third of proteins navigate the secretory pathway, entering this system via the endoplasmic reticulum (ER). They are then transported via cellular compartments, including the Golgi apparatus and transport carriers, to be targeted to their final destination (Lee et al., 2004) . Beyond this apparent simple view, processes underlying protein transport and secretion are gaining continuous complexity with recent demonstrations that cell compartments establish cross regulatory mechanisms with numerous membrane contact sites (Wu et al., 2018) , are endowed of tightly regulated dynamics (Valm et al., 2017) , and stand at the crossroad of signaling pathways where inputs and outputs are integrated and coordinated (Luini and Parashuraman, 2016) .
Yeast genetic studies and in vitro biochemical approaches have initially been used to discover the basal protein transport machinery (Novick et al., 1980; Braell et al., 1984) . More recently, arrayed RNA interference screens at the genome scale or targeting kinases/phosphatases, expanded the list of functional and regulatory components of secretory pathways in metazoan cells (Asensio et al., 2010; Bard et al., 2006; Chia et al., 2012; Simpson et al., 2012; Wendler et al., 2010) . In these studies, artificial secreted reporters such as horseradish peroxidase (HRP) or firefly luciferase preceded by a signal sequence (ss) were used for detection. Alternatively, Golgi membrane organization or transport to the cell surface of fluorescently labeled exogenous transmembrane proteins such as Vesicular Stomatitis Virus-G (VSV-G) were detected using high throughput imaging or flow cytometry systems. While these approaches were useful, their implementation to different cell types, cargo proteins and various environmental conditions remains difficult.
Indeed, a current challenge is to understand how secretory pathways are specialized and regulated following intrinsic demands, external cues, and eventually altered in diseases. Towards this objective, versatile platforms are needed to uncover factors involved in protein transport in various physiological and pathophysiological contexts. Recent developments of the bacterial Clustered Regulatory Interspaced Palindromic Repeats (CRISPR)-associated nuclease Cas9 technology paired with libraries of single-guide RNAs (sgRNAs), have been successfully used to perform pooled genome-wide screening (Shalem et al., 2015) , where targeted genes can be disrupted (Shalem et al., 2014) , gene expression inhibited (CRISPRi) or activated (CRISPRa) (Gilbert et al., 2014) .
Here, we developed a new and efficient strategy using a pooled genome-wide CRISPRi screen to identify genes involved in protein trafficking and secretion in mammalian cells, and we highlight the contribution of newly identified factors in these processes.
Results and discussion
Dual fluorescent reporter for protein transport.
We first established a HeLa cell line stably expressing the GFP-tagged TAC protein (interleukin-2 receptor), and the nuclease-dead Cas9 (dCas9) fused to the KRAB repressor protein (HeLa TAC-GFP dCas9-KRAB cells). TAC protein, which contains a single transmembrane domain (TMD) and localizes at the cell surface, represents a straightforward reporter to investigate protein transport along the ER-Golgi secretory pathway ( Fig. 1A to C and Fig. S1A to F) (Stanley and Lacy, 2010) . dCas9-KRAB fusion protein in association to sgRNA targeting the transcription start site (TSS) of specific genes (CRISPRi system) is a powerful tool to inhibit gene expression (Gilbert et al., 2013) . We first tested our reporter system by incubating cells with brefeldin A (BFA), an inhibitor of protein transport through the ER and Golgi membranes (Misumi et al., 1986) . Flow cytometry analysis demonstrated a decrease of TAC surface expression upon BFA treatment (Fig. S1G) . Incubation of cells with trypsin, a protease that cleaves most proteins expressed at the cell surface, strongly reduced TAC surface expression that recovered after 18 h in trypsin-free medium. In these conditions, BFA treatment prevented TAC surface expression recovery (Fig. 1D) .
We then validated our cell line by analyzing TAC expression after knockdown of genes essential for secretory pathway function. Cells were infected with lentivirus to express control sgRNA (Gal4) or sgRNAs targeting the TSS of SCFD1, which regulates SNARE complex assembly (Carr and Rizo, 2010) , Sec24A, a COPII vesicular coat subunit (Wendeler et al., 2007) , or Sec61A, which promotes translocation of secreted and membrane proteins into the ER (Voorhees and Hegde, 2016) . Tight quality-control is associated with the co-translational insertion of nascent polypeptide chains upon emergence from the ribosomal exit tunnel, and a translocation defect of nascent polypeptide chains in the ER leads to their degradation (Brandman and Hegde, 2016) . For this reason, downregulation of Sec61A is an appropriate control to monitor TAC expression when TAC translation is altered. Seven days after infection, total and surface TAC expressions were monitored by flow cytometry. Sec61A knockdown, as expected, reduced both surface and total TAC expression. However, SCFD1 and Sec24A knockdown strongly reduced TAC surface transport without affecting the total TAC expression ( Fig. 1E and Fig. S1H ). Cells were also analyzed for the ratio surface/total TAC expression. Upon SCFD1 and Sec24A knockdown, a strong enrichment in the lower quartile was observed related to a decrease of TAC surface expression.
Interestingly, no enrichment in one or the other quartile was detected in Sec61A-depleted cells, where both surface and total TAC expression were reduced ( Fig. 1E) . Altogether, these results established our cell line as an efficient and specific cellular platform to monitor secretory pathway function, and prompted us to use it to perform a pooled genome-wide CRISPRi screen.
Genome-wide CRISPRi screen mostly identifies genes involved in protein transport.
HeLa TAC-GFP dCas9-KRAB cells were transduced with the CRISPRi-v2 library (Horlbeck et al., 2016a) at a low MOI (0.3), and selected for stable integration with puromycin. Seven days after transduction, cells were separated by FACS into a high and low surface/total TAC expression ratio, selecting upper and lower quartiles, respectively. Genomic DNA was then isolated and read counts of sgRNAs obtained by deep sequencing to determine the abundance of each sgRNA in the two cell fractions ( Fig. 1F) . Subsequent analysis using MAGeCK (Li et al., 2014 ) allowed the identification of many genes whose downregulation modified TAC transport at the cell surface (Table S1, and Fig. 1G ).
In the lower quartile, Gene Ontology (GO) term enrichment analysis of the 100 top ranked genes revealed that knockdown of genes encoding components of "Golgi vesicle transport" was the main functional category inhibiting TAC transport ( Fig. 1G and H) . Genes involved in "toxin transport", "antigen processing and presentation", "Golgi organization" were also highly enriched. In the upper quartile, the knockdown of genes encoding known components involved in "protein exit form the ER", "response to topologically incorrect protein", "ER to cytosol transport", "response to ER stress" as well as components involved in post-translational modification were the main functional categories promoting TAC transport ( Fig. 1I) . Altogether, these results clearly demonstrated the value of our approach to identify genes involved in secretory pathway function and organization.
A secondary screen identifies new factors required for protein transport and secretion.
Sixty-three genes identified either in the lower or upper quartiles were selected for a secondary screen using a secretion assay based on the detection of HRP fused to a signal sequence (ss-HRP) (Von Blume et al., 2009) . Selected genes were knocked down in HeLa-ss-HRP after transfection of smart pool short-interfering RNAs (siRNAs) pre-arrayed in a 96-well plate. After 3 days, cells were washed, incubated with complete medium, and cell lysates and medium harvested after 8 h for HRP quantification.
As a positive control, in SCFD1-depleted cells, a strong signal in the cell lysate associated to a low signal detected in the medium demonstrated a clear defect of HRP secretion and its resulting accumulation inside cells (in red on Fig. 2A) . Interestingly, this approach identified several genes with poorly characterized function, for which the knockdown inhibited or promoted HRP secretion. They included for example WDR7, YPEL5, TMEM167A, FAM46A, as well as the ubiquitin specific peptidase USP32 and the G protein coupled receptor GPR162. Future analyses will help to dissect their role. We selected 4 genes for further analysis (in green on Fig. 2A) , those encoding the Coiled-Coil Domain-Containing Protein 151 (CCDC151), and 157 (CCDC157), C10orf88, and the Tetratricopeptide Repeat Protein 17 (TTC17). They were highly enriched in the lower quartile of the CRISPRi screen, their knockdown strongly inhibited HRP secretion, and they encode proteins with a poorly defined or unknown function.
First, we aimed to confirm the effect of their knockdown on TAC protein transport. HeLa TAC-GFP cells were transfected with specific siRNA and, after three days, knockdown efficiency monitored by RT-PCR ( Fig. 2B) . Flow cytometry analysis revealed that downregulation of the selected genes inhibited TAC expression at the cell surface, confirming that they were true hits ( Fig. 2C) . We also found that their siRNA-mediated downregulation reduced the transport of the Major Histocompatibility Complex-I (MHC-I), an endogenous cargo protein trafficked along the ER-Golgi secretory pathway to the cell surface ( Fig. 2D) . Altogether, these results demonstrated that the selected candidate genes were required for both exogenous and endogenous cargo protein transport.
The newly identified factors are essential for secretory pathway organization.
Next, we assessed the role of newly identified factors on the morphology of ER, ER exit site (ERES), cis Golgi membranes and trans Golgi network (TGN) using antibodies targeting calnexin (CNX), Sec31A, GM130 and TGN46, respectively. As a control, in SCFD1-depleted cells, Golgi membranes were completely fragmented, characterized by GM130-and TGN46-positive punctae dispersed throughout the cytoplasm. Interestingly, this phenotype was also observed after CCDC151 and C10orf88 downregulation ( Fig. 3A and C and Fig. S2A ). Conversely, after TTC17 and CCDC157 knockdown, Golgi membranes remained localized in the perinuclear area, but presented an extensively dilated and/or expanded organization and a very specific ring-shaped structure, respectively ( Fig. 3D and E and Fig. S2A ). ERES distribution was only slightly altered upon candidate gene knockdown (Fig. 3B) , and no obvious changes were observed in the distribution and morphology of the ER (Fig. S2B) .
To address the role of the selected factors, we looked for interacting partners. BioPlex network encompasses results aiming at identifying binding partners of proteins encoded by the human genome (Huttlin et al., 2017 (Huttlin et al., , 2015 . Interrogation of this resource identified TTC17-interacting proteins including exclusively ER and Golgi resident proteins and cargo proteins transported along the secretory pathway ( Fig. 3F) . Interacting partners of CCDC151 include the SNARE-associated protein SNAPIN, GTPase Rab-Like protein 5 (RABL5) and Golgin A5 ( Fig. 3G) . Interacting partners of C10orf88 include Rab protein GDI2, clathrin Heavy chain, clathrin adaptors accessory protein CCDC91 and plasma membrane proteins NCKAP1 and LILRB4 (Fig. 3H) . The BioPlex resource does not contain a network for CCDC157. Taken together, these data support a direct role of the selected factors on the secretory pathway function, prompting us to uncover their site of action.
A Pfam domain analysis (Finn et al., 2016) or TMHMM software (Krogh et al., 2001 ) did not predict TMD for the selected factors, whereas HMMTOP algorithm (Tusnády and Simon, 2001 ) yielded 1 TMD for TTC17. Moreover, their subcellular distribution has not been unambiguously established. To assess localization of the selected factors, we performed immunofluorescence microscopy on HeLa cells, after permeabilization with digitonin and extensive washing, using specific antibodies directed against the endogenous proteins. This approach revealed a close proximity between CCDC151 and the centrosomal marker Centrin-3 ( Fig. 3I and Fig. S2C ). This location is consistent with the interacting partners of CCDC151 revealed by BioPlex and the Golgi membrane phenotype observed in CCDC151-depleted cells ( Fig. 3A and C) . Indeed, interacting partners of CCDC151 included CEP170 (Fig. 3G) , a key centrosome component that functions as a microtubule-organizing center, essential for the perinuclear localization of Golgi membranes (Rios and Bornens, 2003) . Hence, we hypothesized that CCDC151 is a bridging factor between the centrosome and Golgi membranes via interaction with the Golgin A5 and CEP170, thereby contributing to the maintenance of Golgi architecture. Disruption of this functional link may result in Golgi membrane dispersion throughout the cytoplasm after depletion of CCDC151 ( Fig. 3A) . Of interest, our results also revealed the presence of TTC17 and CCDC157 on Golgi membranes ( Fig. 3J and K) . A residual signal of C10orf88 was mainly diffuse in the cytoplasm (Fig. 3L) . The subcellular location of TTC17 and CCDC157, and the consequence of their knockdown on Golgi membranes prompted us to further characterize these two factors.
CCDC157 is required for fusion events with Golgi membranes.
A permanent flux of membranes goes to and from the Golgi complex. BFA has been regularly used to study Golgi membrane dynamics, inducing a complete fusion of Golgi membranes with the ER and endosomes via tubule formation (Lippincott-Schwartz et al., 1989) and the relocation of peripheral matrix Golgi proteins such as GM130 and GRASP65 to the ERES (Mardones et al., 2006 ). First, we tested whether Golgi membrane reorganization was altered upon BFA treatment in TTC17-and CCDC157-depleted cells. HeLa cells were transfected with specific siRNAs and after 3 days, treated with BFA. Immunofluorescence microscopy revealed that GM130 completely dispersed upon 30 min of BFA treatment in control cells and in most of CCDC157-and TTC17-depleted cells (Fig. 4A ). Next, we tested the effect of CCDC157 and TTC17 knockdown on Golgi membrane reassembly after BFA washout, which is mediated by fusion events. In control and TTC17-depleted cells, Golgi membrane reassembly occurred in most cells after 60 min, while in CCDC157-depleted cells, GM130 remained completely dispersed ( Fig. 4A) . These results suggested that Golgi membrane reassembly after BFA washout was strongly dependent on CCDC157.
We next assessed the impact of CCDC157 knockdown on the distribution of transport carriers known to fuse with Golgi membranes. We performed immunofluorescence microscopy experiments using antibodies targeting the transferrin receptor (TfR), which is constitutively transported from the TGN to the cell surface and retrieved to Golgi membranes after endocytosis (Snider and Rogers, 1985) , and EEA1, a marker of early endosomes, critical for endosomal trafficking (Barysch et al., 2009 ). In TTC17depleted cells, the distribution of TfR and EEA1 were not markedly affected compared to control cells ( Fig. 4B and C) . However, in CCDC157-depleted cells, the distribution of both TfR and EEA1 were strongly altered, most of the signal being restricted to the perinuclear area in the form of enlarged TfRand EEA1-positive vesicles, surrounded by Golgi membranes (Fig. 4B to D) . These results suggested that, in the absence of CCDC157, incoming carriers deriving from plasma membrane and endosomes accumulate and collapse in close proximity of Golgi membranes, strengthening CCDC157 as an important factor for the fusion of transport carriers with the Golgi complex.
TTC17 is required for the polarized arrangement of Golgi cisternae and post-translational modifications.
In addition to being a gate entrance and a major sorting station, the Golgi apparatus allows posttranslational modifications such as glycosylation. This process is spatially regulated, being dependent on accurate localization of specific enzymes acting sequentially from the cis-to trans-Golgi cisternae. Does altered Golgi membrane organization in CCDC157-and TTC17-depleted cells impact Golgi polarization and create glycosylation defects? To address this, we first assessed the localization of GM130 and TGN46, cis-and trans-Golgi markers respectively, in cells incubated in presence or absence of nocodazole. Nocodazole is a microtubule-depolymerizing agent that causes Golgi stack dissociation from each other and their dispersion (Cole et al., 1996) , facilitating the visualization of Golgi-resident protein segregation in individual Golgi stacks ( Fig. 5A and D) . In control cells, GM130 and TGN46 staining only partially co-localized. Similar results were obtained in CCDC157-depleted cells. Conversely, in TTC17-depleted cells, GM130 and TGN46 staining showed a high degree of co-localization ( Fig. 5A to   E ), suggesting that protein localization in their respective cisternae was perturbed with no further segregation of cis-and trans-Golgi markers. In addition, we observed that upon TTC17 knockdown, nocodazole failed to induce complete Golgi membrane fragmentation although the microtubule cytoskeleton was entirely depolymerized (Fig. 5C ). We hypothesized that the dramatic alteration of Golgi membrane architecture upon TTC17 depletion prevents efficient Golgi stack dissociation.
We next tested whether the loss of Golgi polarization in TTC17-depleted cells impairs cargo protein glycosylation. The lysosomal protein LAMP2 is highly glycosylated during its transport across the secretory pathway, increasing its molecular weight (Stewart et al., 2017) . In control and CCDC157depleted cells, immunoblotting analysis revealed LAMP2 mainly as a fully processed 100 kDa band.
However, in TTC17-depleted cells, a smaller form of ~80 kDa became apparent, indicating incomplete LAMP2 processing, likely related to a glycosylation defect ( Fig. 5F) . These results established TTC17 as an important factor for Golgi membrane structure and polarized arrangement of Golgi cisternae, conditioning efficient cargo protein processing and transport.
In summary, we present a powerful unbiased pooled genome-wide CRISPRi screen to identify new factors involved in protein transport and secretion. The ability of our strategy to highlight factors in these processes relied on a combination of key parameters enabling to specifically detect TAC transport alterations and preventing cell death upon systematic gene downregulation. They included an efficient dual fluorescent reporter associated to a CRISPRi-mediated knockdown and an early FACS-based cell selection after lentivirus transduction.
We further characterized two of the newly identified factors. While additional studies will be required to fully decipher their functions, our data suggest that like other coiled-coil proteins (Wong and Munro, 2014; Cheung and Pfeffer, 2016) , CCDC157 could be part of a tethering complex required for fusion event with Golgi membranes. On the other hand, phenotypes observed in TTC17-depleted cells associated to its interacting partners involved in sphingomyelin metabolism (ENPP7 and NAAA, Fig. 3F ) (Tsuboi et al., 2007; Duan et al., 2003) , suggest that TTC17 could play a role in the production and distribution of particular lipids, a critical parameter for Golgi complex organization and function (Campelo et al., 2017; van Galen et al., 2014) .
Altogether, we anticipate that the list of identified genes as well as the adaptation of this screening platform to specific cargo protein, cell types, or particular environmental challenges can open stimulating perspectives for a deeper understanding of secretory pathway processes in health and disease.
Materials and methods

Antibodies, reagents and plasmids
Antibodies used in this study included: mouse monoclonal antibodies anti-TAC conjugated to PE (BioLegend, #356103), anti-GM130 (BD Biosciences, #610822), anti-Sec31A (BD Biosciences, (Gilbert et al., 2013) ). pU6-sgRNA EF1Alpha-puro-T2A-BFP, a gift from Jonathan Weissman (Addgene plasmid #60955, (Gilbert et al., 2014) ). pCMV-VSV-G, a gift from Bob Weinberg (Addgene plasmid #8454, (Stewart et al., 2003) ). psPAX2, a gift from Didier Trono (Addgene plasmid #12260). hCRISPRi-v2 genome-wide library, a gift from Jonathan Weissman (Addgene pooled library #83969, (Horlbeck et al., 2016a) ).
Cell culture
All cell lines, HeLa cells (ATCC), HeLa-ss-HPR cells (a gift from Vivek Malhotra), HeLa TAC-GFP cells (this paper), HeLa TAC-GFP dCas9-KRAB cells (this paper) and HEK293T cells (ATCC) were grown in complete medium consisting of Dulbecco's modified Eagle's medium (DMEM, Molecular Probes, #D6546) containing 10% fetal bovine serum (FBS, ThermoFisher, #10270-106), 100U/ml penicillin, 100 µg/ml streptomycin (Sigma, #P0781) and 2 mM L-glutamine (Sigma, #G7513) at 37°C with 5% CO 2 . All cell lines were tested every month using ATCC universal mycoplasma detection kit (#ATCC ® 30-1012K TM ) to confirm they were clear of contamination by mycoplasma.
To generate a HeLa cell line stably expressing GFP-tagged TAC protein, We transfected HeLa cells with pCMV6-AC-IL2R-GFP (Origene plasmid #RG215768) using TransIT ® -2020 transfection reagent (Mirus, #5405), following the manufacturer's recommendations, and after two days, transfected cells were selected with 600 µg/ml G-418 (Sigma, #4727878001) during one week. Then, GFP-positive cells were isolated by fluorescence-activated cell sorting (FACS), and single cells were collected in 96-well plates. After expansion into 6-well format, TAC-GFP expression was assessed from clonal lines by flow cytometry and immunofluorescence microscopy analysis. The GFP signal allows monitoring the total TAC expression whereas the pool expressed at the cell surface can be assessed using a phycoerythrin (PE)-conjugated antibody, which recognizes the extracellular domain of the TAC protein. To generate HeLa TAC-GFP dCas9-KRAB cells, we transduced HeLa TAC-GFP cells with lentivirus to express dCas9-KRAB fusion protein (see section "Lentivirus production and transduction"). After two days, transduced cells were sorted for BFP-positive cells. 
siRNA-mediated knockdown
CRISPRi-mediated knockdown
Gene-specific CRISPRi sgRNA oligonucleotide sequences used were: Gal4 5'-GAACGACTAGTTAGGCGTGTA-3', Sec61A 5'-GGCTAGCACTGACGTGTCTCT-3', SCFD1 5'-GAGCAGCCAGTATTCGGGAA-3', Sec24A 5'-GACATGATGACTGGGTTGGA-3'. Forward sgRNA oligonucleotides were designed with 5' TTG and 3' GTTTAAGAGC overhangs and reverse sgRNA oligonucleotides were designed with 5' TTAGCTCTTAAAC and 3' CAACAAG overhangs.
Oligonucleotides were diluted to 100 µM in water and 1 µl of forward and reverse oligo were combined in a 50 µl reaction containing 200 mM potassium acetate, 60 mM HEPES, pH 7.4 and 4 mM magnesium acetate. Oligonucleotides were incubated for 5 min at 95°C and slow cooled (0.1 degrees/sec) for annealing. Annealed oligos were diluted 1/40 and 1 µl of insert was ligated into 10 ng of digested vector (pU6-sgRNA EF1Alpha-puro-T2A-BFP, Addgene plasmid #60955 digested with BstXI and Blpl) using T4 DNA ligase (ThermoFisher, #EL0011) in a final volume of 10 µl. Ligation was allowed to proceed for 1 h. Ligated products were transformed into DH5α bacteria (ThermoFisher, #18258012). After lentivirus production (see section "Lentivirus production and transduction"), TAC-GFP-dCas9-KRAB HeLa cells were infected and knockdown efficiency was monitored 7 days post-transduction by RT-PCR. TAC-GFP expression was assessed by flow cytometry analysis.
Lentivirus production and transduction
Lentivirus was generated in HEK293T cells using TransIT ® -293 transfection reagent (Mirus, For CRISPRi-mediated knockdown and a pooled genome-wide CRISPRi screen, 48 h after infection, 2µg/ml puromycin (Sigma, St. Louis, MO, #P9620) was added to select transduced cells.
Pooled genome-wide CRISPRi screen and Illumina library construction and sequencing
Approximately 200 million HeLa cells stably expressing TAC-GFP and dCas9-KRAB fusion protein were transduced with the hCRISPRi-v2 library (Addgene #83969) at an MOI of 0.3 to ensure no more than one viral integration event per cell. The CRISPi-v2 library comprised 104,535 sgRNAs targeting 18,905 human genes. Each sgRNA of the library targeted the TSS of the respective genes in regions of low nucleosome occupancy avoiding genomic DNA compaction to impact Cas9 binding (Horlbeck et al., 2016b; a) . Two days after infection, an aliquot of cells was analyzed by FACS to confirm transduction efficiency and then, cells were cultured with 2 µg/ml puromycin (Sigma) to remove uninfected cells. After an 5 additional days, cell were trypsinized, washed extensively and plated with fresh medium for 18 h allowing recovery of transmembrane protein expression at the cell surface. Cells were then detached using 0.5 mM EDTA, resuspended in blocking buffer (OptiMEM containing 5% FBS) and stained for TAC surface expression using a PE-conjugated anti-TAC antibody during 1 h at 4°C. Finally, live cells were sorted by FACS following the PE/GFP fluorescence ratio, selecting the upper and lower quartile, respectively. Ten million cells were sorted for each fraction. Cell sorting was performed using a FACSAria sorter. Two independent screens were performed. After FACS sorting, cells were centrifuged and pellets were frozen until processing. following the manufacturer's recommendations, and quantified on a Qubit and run on a Bioanalyzer (Agilent). The four libraries were pooled to a total concentration of 10 nM and subjected to DNA sequencing on a HiSeq2500 (Illumina) sequencer. Samples were sequenced with the rapid run mode of the single-ended 50 pb, following the manufacturer's recommendations, using the custom sequencing primer: 5'-GTGTGTTTTGAGACTATAAGTATCCCTTGGAGAACCACCTTGTTG-3'.
For data analysis, raw sequencing reads were aligned to the v2CRISPRi library sequences using Bowtie 2, and data were analyzed using MaGECK algorithm (Li et al., 2014) . For genes with multiple independent TSS targeted by the sgRNA library, phenotype and P-values were calculated independently for each TSS. The CRISPRi screen was performed twice.
Secondary screen using an HRP secretion assay
HeLa cells stably expressing ss-HRP were transfected in 96-well plate pre-arrayed with the 
Flow cytometry
After CRISPRi-or siRNA-mediated target gene knockdown, cells were washed with PBS and detached by incubation with 0.5 mM EDTA for 10 min in PBS. Cells were then resuspended in blocking buffer (OptiMEM containing 5% FBS) and live cells were incubated for 1 h at 4°C with an anti-TAC antibody conjugated to PE. GFP and PE fluorescence were collected on a LSR Fortessa (BD Biosciences) and analyzed using FlowJo software (FlowJo, LLC). For cytosol washout prior immunofluorescence microscopy, cells were washed twice with room temperature KHM buffer (125 mM potassium acetate, 25 mM HEPES-KOH, pH 7.2, and 2.5 mM magnesium acetate). Cells were then permeabilized by incubation in KHM buffer containing 30 µg/ml digitonin for 5 min on ice followed by a wash for 5 min at room temperature with KHM buffer. Cells were subsequently fixed with 4% paraformaldehyde and processed for immunofluorescence microscopy.
Immunoblot
This procedure allows removing the soluble cytoplasmic pool of proteins, highlighting their potential association with intracellular compartments.
RT-PCR
Total RNA was extracted from HeLa cells using the RNAeasy Plus Mini kit (QIAGEN, #74134) and cDNAs were synthesized with the Cloned AMV First-Strand cDNA Synthesis kit (Invitrogen, #12328032) and oligo d(T) 20 according to the manufacturer's instruction. cDNA of indicated genes were amplified by PCR using Q5 HF DNA polymerase (NEB, #M0491L) and the following specific primers: 
Statistical analysis
Data are presented as mean ± s.d. Differences in the mean values between 2 groups were assessed by 2-tailed Student t-test. *P<0.05 was taken to imply statistical significance. In figure 3D , difference between 2 groups was assessed by Mann-Whitney U test. **P<0.01. Table S1 shows MaGECK analysis of the CRISPRi screen replicate. TTC17 knockdown alter polarized arrangement of Golgi cisternae To test further the specificity of the anti-TAC antibody used, TAC surface expression was analyzed by flow cytometry in nucleated cells from blood sample. Only a subpopulation of nucleated cells, most likely the lymphocytes expressed TAC proteins. (C to F) Optimization of experimental conditions to monitore TAC expression by flow cytometry. (C) TAC surface expression in HeLa-TAC-GFP cells (from 1x10 5 to 1x10 6 cells/100µl) were analyzed by flow cytometry using increasing concentrations of anti-TAC-PE antibody. (D) Using conditions establish in (C), TAC surface expression was analyzed on fixed (F) and Lived (L) cells by incubating cells with the anti-TAC-PE antibody during 1 h at room temperature (RT) or at 4°C. (E) Using conditions establish in (C), TAC surface expression was analyzed on Lived (L) cells by incubating cells with the anti-TAC-PE antibody during 1, 2 or 3 h at 4°C. (F) Lived HeLa-TAC-GFP cells were incubated for 2 h at 4°C with the anti-TAC-PE antibody, followed by flow cytometry analysis at T=0, or after 4 and 8 h. TAC surface expression on lived cells maintain 4°C after staining remain stable even after 8h. This control was essential to ensure the stability of the signal during the step of FACS sorting for the pooled genome-wide CRISPR screen. (G) Left panel. HeLa TAC-GFP cells were incubated in presence or absence of 1 µg/ml BFA and at indicated times, cells were washed with PBS, detached by 10 min incubation in PBS containing 0.5 mM EDTA, and surface and total TAC expression was analyzed by flow cytometry. Surface TAC expression was calculated as the ratio of the mean of fluorescence of surface and total TAC expression. Results are shown as the mean ± SD of 3 independent experiments. Right panel. Flow cytometry analysis of Surface and total TAC expression of HeLa TAC-GFP cells at T0 (i) and after incubation in presence of 1 µg/ml BFA during 24 h (ii). (H) HeLa TAC-GFP dCas9-KRAB cells were infected with lentivirus to express control sgRNA (Gal4) or sgRNAs targeting the TSS of SCFD1, Sec24A and Sec61A. Seven days after infection, the knockdown efficiency was monitored by RT PCR. (1)
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(2) Figure S2 : Newly identified factors are essential for Golgi membranes organization. (A and B) HeLa cells were transfected with the indicated siRNA and after 3 days the TGN and the ER organization were assessed by immunofluorescence microscopy using specific antibodies against TGN46 (A) and CNX (B), respectively. (C) CCDC151 localizes at the centrosome. HeLa cells were processed for cytosolic washout. After fixation and permeabilization, the co-localization of the endogenous protein CCDC151 (green) with Centrin 3 (red), a centrosomal marker, was monitored by immunofluorescence microscopy. Nuclei are stained with Dapi.
